SCHEDULE 13G: Harris Kupperman and Affiliates Disclose 5.5% Passive Stake in INmune Bio Inc.

Harris Kupperman, through various affiliated entities including Praetorian Capital and Mongolia Growth Group, has disclosed a combined passive beneficial ownership of 5.5% in INmune Bio Inc., totaling 1,238,963 shares.

Summary

• Harris Kupperman, along with Praetorian PR LLC, Praetorian Capital Fund LLC, Praetorian Capital Management LLC, Mongolia (Barbados) Corp., and Mongolia Growth Group Ltd., collectively reported beneficial ownership of INmune Bio Inc. common stock.
• The filing, a Schedule 13G, indicates a passive investment purpose, with the reporting persons certifying that the securities were not acquired to change or influence the control of the issuer.
• As of January 15, 2025, Harris Kupperman is deemed to beneficially own 1,238,963 shares, representing approximately 5.5% of INmune Bio Inc.'s outstanding common stock.
• Praetorian Capital Fund LLC, Praetorian PR LLC, and Praetorian Capital Management LLC each reported beneficial ownership of 1,103,210 shares, equating to approximately 4.9% of the outstanding shares.
• Mongolia (Barbados) Corp. and Mongolia Growth Group Ltd. each reported beneficial ownership of 135,753 shares, representing approximately 0.6% of the outstanding shares.
• The reported share counts include shares issuable upon the exercise of warrants (181,800 shares for Praetorian Fund) and shares underlying call options (79,200 shares for Praetorian Fund, 10,000 shares for Mongolia (Barbados) Corp.) exercisable within 60 days.
• The percentages are calculated based on 22,172,451 shares outstanding as of October 31, 2024, as disclosed in INmune Bio Inc.'s Form 10-Q, plus the exercisable warrants and options.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, which is neutral in sentiment. It does not contain positive or negative operational news.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of a significant passive ownership stake by an investment group and its principal, Harris Kupperman, in a publicly traded biotechnology company. It does not provide specific insights into INmune Bio Inc.'s operational performance or industry trends, but rather reflects an investment position.

Stakeholder Impact

• Shareholders: The disclosure of a significant passive stake by a known investor like Harris Kupperman could be viewed positively by some shareholders, indicating investor confidence, or neutrally as a routine disclosure.

Key Dates

Keywords

INmune Bio Inc., Harris Kupperman, Praetorian Capital, Mongolia Growth Group, Schedule 13G, Beneficial Ownership, SEC Filing, Common Stock, Investment, Passive Stake